| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 03/30/2006 | CA2575838A1 Anti-cd154 antibodies |
| 03/30/2006 | CA2574821A1 Her2 antibody composition |
| 03/30/2006 | CA2571272A1 Anti-lympho- plus anti-monocytes globulin preparation for inhibiting immune responses |
| 03/30/2006 | CA2566840A1 Bacillus anthracis spore specific antobodies |
| 03/29/2006 | EP1640381A2 Neurotrophic growth factor |
| 03/29/2006 | EP1639374A1 Method of diagnosing sars corona virus infection |
| 03/29/2006 | EP1639371A1 Methods for identifying agents, which regulate cytokines |
| 03/29/2006 | EP1639112A2 Novel beta-actin and rps21 promoters and uses thereof |
| 03/29/2006 | EP1639095A2 Method to increase protein production in culture |
| 03/29/2006 | EP1639092A2 Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof |
| 03/29/2006 | EP1639085A2 Modified human acid sphingomyelinase having increased activity, and methods for making the same |
| 03/29/2006 | EP1639015A1 Antibodies to the fuel oxygenate mtbe and use thereof in immunoassays |
| 03/29/2006 | EP1639014A2 Aglycosyl anti-cd154 (cd40 ligand) antibodies and uses thereof |
| 03/29/2006 | EP1639013A2 Pan-kir2dl nk-receptor antibodies and their use in diagnostik and therapy |
| 03/29/2006 | EP1639012A2 Suppression of transplant rejection |
| 03/29/2006 | EP1639011A2 Polypeptides |
| 03/29/2006 | EP1639010A2 Surrogate therapeutic endpoint for anti-ctla-4 based immunotherapy of disease |
| 03/29/2006 | EP1639009A1 Fab library for the preparation of anti vegf and anti rabies virus fabs |
| 03/29/2006 | EP1639000A2 Compositions and methods for the diagnosis and treatment of tumor |
| 03/29/2006 | EP1638999A2 Compositions and methods for increasing bone mineralization |
| 03/29/2006 | EP1638996A1 Hiv immunogenic complexes |
| 03/29/2006 | EP1638606A2 Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof |
| 03/29/2006 | EP1638604A2 Passive immune therapy against malignant melanoma |
| 03/29/2006 | EP1638603A1 Methods for the prevention and treatment of diseases caused by an inflammatory response mediated by endogenous substance p by using anti-substance p antibodies |
| 03/29/2006 | EP1638600A2 Method of inhibiting receptor tyrosine kinases with an extracellular antagonist and an intracellular antagonist |
| 03/29/2006 | EP1638587A2 Contraceptive methods and compositions related to proteasomal interference |
| 03/29/2006 | EP1638514A2 Use of epha4 and modulator or epha4 for diagnosis, treatment and prevention of cancer |
| 03/29/2006 | EP1638512A2 Ligands that bind to the amyloid-beta; precursor peptide and related molecules and uses thereof |
| 03/29/2006 | EP1638510A2 Multivalent carriers of bi-specific antibodies |
| 03/29/2006 | EP1320552B1 Method for producing human anti-thymocyte immunoglobulins |
| 03/29/2006 | EP1305402B1 Lipo-viro-particle complexes, preparation method and uses |
| 03/29/2006 | EP1290197B1 Leader peptides for enhancing secretion of recombinant protein from a host cell |
| 03/29/2006 | EP1290160B1 Human pellino polypeptides |
| 03/29/2006 | EP1222266B1 Pca3 messenger rna in benign and malignant prostate tissues |
| 03/29/2006 | EP1137943B1 Cancer detection method and reagents |
| 03/29/2006 | EP1079847B1 Osteoporosis treatment |
| 03/29/2006 | EP1007554B1 Oil bodies and associated proteins as affinity matrices |
| 03/29/2006 | EP1005363B1 Recombinant dimeric envelope vaccine against flaviviral infection |
| 03/29/2006 | EP0990031B1 Tumor necrosis factor receptor 5 |
| 03/29/2006 | EP0975748B1 Methods for identifying nucleic acid molecules encoding (poly)peptides that interact with target molecules |
| 03/29/2006 | EP0944722B1 Pituitary-tumor-transforming-genes, and related products |
| 03/29/2006 | EP0918797B1 Humanized immunoglobulin reactive with alpha4beta7 integrin |
| 03/29/2006 | EP0751709B2 Use of bcl-2 for the manufacture of medicaments for the therapeutic treatment and prevention of diseases |
| 03/29/2006 | CN1753991A Monoclonal antibody, gene encoding the same, hybridoma, medicinal composition and diagnostic reagent |
| 03/29/2006 | CN1753912A Antibodies against PD-1 and uses therefor |
| 03/29/2006 | CN1753911A Chimeric and humanized antibodies to alpha5beta1 integrin that modulate angiogenesis |
| 03/29/2006 | CN1753694A Remedy for spinal injury containing interleukin-6 antagonist |
| 03/29/2006 | CN1753693A Uses of anti-insulin-like growth factor I receptor antibodies |
| 03/29/2006 | CN1753692A Lymphotoxin beta receptor agents in combination with chemotherapeutic agents |
| 03/29/2006 | CN1753689A The use of cytochrome p450 enzyme cyp2wi as a drug traget for cancer therapy |
| 03/29/2006 | CN1752212A Process for preparing PGRP (31-98) fragment by gene recombining technique |
| 03/29/2006 | CN1752107A Preparation method of anti apoA1, apoB antibody and reagent box used for detecting apoAI, apoB |
| 03/29/2006 | CN1752106A Method of manufacturing human antibody possessing bioreceptor synergist, antagonist and/or inverse synergist |
| 03/29/2006 | CN1752105A Biomimetic affinity purification method of vitellus immune globulin |
| 03/29/2006 | CN1752104A Monoclonal antibody of synapse protein gamma and its application |
| 03/29/2006 | CN1247784C Novel elongase gene and method for producing multiple-unsaturated fatty acids |
| 03/29/2006 | CN1247780C Mammalian sytokine-like polypeptide-10 |
| 03/29/2006 | CN1247775C Attenuated cattle viral diarrhoea virus |
| 03/29/2006 | CN1247615C Purification of human myocardium troponin I and preparation method of its monoclonal anti-body |
| 03/29/2006 | CN1247613C Novel omega-conotoxin peptides |
| 03/28/2006 | US7019125 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 03/28/2006 | US7019119 Protein belonging to the TNF superfamily involved in signal transduction, nucleic acids encoding same, and methods of use thereof |
| 03/28/2006 | US7019118 Antiinflammatory agents; rheumatic disease |
| 03/28/2006 | US7019116 PRO 1387 polypeptides |
| 03/28/2006 | US7019115 Nucleotide sequences coding membrane protein for use as antiproliferative/antitumor/antiinflammatory/anticarcinogenic agents |
| 03/28/2006 | US7019111 Glycosylated ligand/receptor specificity exchangers specific for bacterial adhesion receptors |
| 03/28/2006 | US7018839 Peptide from soluble form of acetylcholinesterase, active as a calcium channel modulator |
| 03/28/2006 | US7018810 Chordin-like molecules and uses thereof |
| 03/28/2006 | US7018809 gene expression of heavy and light chain Fv fragments in prokaryotic host cell cultures, then recovering the fab fragment secreted to the periplasm under conditions that maintain cysteine residue as free thiols, which can then react with free thiol of other fragments, labels or drugs; homogeneity; purity |
| 03/28/2006 | US7018802 Electrochemiluminescent enzyme immunoassay |
| 03/28/2006 | US7018791 chaperone proteins; biochemical immobilization; competitive binding; drug screening |
| 03/28/2006 | US7018639 polypeptide and optionally carrier and/or adjuvants having haemolysin activity used for inoculation against gramnegative bacteria; immunology |
| 03/28/2006 | US7018632 Isolation of tumor cells; incubation |
| 03/28/2006 | US7018627 administering mammals macrophage derived chemokine(MDC) antagonists comprising monoclonal, polyclonal or single chain antigen binding proteins, to attenuate allergies characterized by eosinophil accumulation |
| 03/28/2006 | US7018626 Chimeric IL-10 |
| 03/28/2006 | CA2106719C Reshaped monoclonal antibodies against an immunoglobulin isotype |
| 03/23/2006 | WO2006031825A2 Humanized antibodies against west nile virus and therapeutic and prophylactic uses thereof |
| 03/23/2006 | WO2006031653A2 Humanized anti-5t4 antibodies and anti-5t4 antibody / calicheamicin conjugates |
| 03/23/2006 | WO2006031363A2 Compositions and methods for the therapy and diagnosis of lung cancer |
| 03/23/2006 | WO2006030883A1 Method of producing monoclonal antibody |
| 03/23/2006 | WO2006030318A2 PROTECTIVE ANTI-GLUCAN ANTIBODIES WITH PREFERENCE FOR β-1,3-GLUCANS |
| 03/23/2006 | WO2006030238A1 Antibody libraries |
| 03/23/2006 | WO2006029879A2 Anti-ox40l antibodies |
| 03/23/2006 | WO2006029578A1 Interleukin-15 antagonist peptide |
| 03/23/2006 | WO2006029497A1 Cancerous disease modifying antibodies |
| 03/23/2006 | WO2006029459A1 Antibodies specific for hepatocellular carcinoma and other carcinomas and uses thereof |
| 03/23/2006 | WO2006005520A3 Means and methods for controlling flowering in plants |
| 03/23/2006 | WO2005118642A3 Bispecific fusion antibodies with enhanced serum half-life |
| 03/23/2006 | WO2005102938A3 Antibodies specific for bcr-abl fusion protein and uses thereof |
| 03/23/2006 | WO2005095975A3 Anti-fungal target genes |
| 03/23/2006 | WO2005058967A3 Novel anti-insulin/igf-i hybrid receptor or anti-insulin/igf-i hybrid receptor and igf-ir antibodies and uses thereof |
| 03/23/2006 | WO2005047459A3 Sars nucleic acids, proteins, antibodies, and uses thereof |
| 03/23/2006 | WO2005047456A3 Anti-idiotype antibodies of the human monoclonal antibody sc-1, and their production and use |
| 03/23/2006 | WO2005042743A3 Humanization of antibodies |
| 03/23/2006 | WO2005037209A3 A method for the separation anti-amyloid beta antibody with amyloid beta peptide |
| 03/23/2006 | WO2005013802A3 Trefoil factor 3 (tff3) as a target for anti-cancer therapy |
| 03/23/2006 | WO2005003325A3 Inhibition of viral pathogenesis |
| 03/23/2006 | WO2004087057A3 Methods for inhibition of angiogenesis |
| 03/23/2006 | WO2004073659A3 HIV gp120 MIMOTOPE ANTIGEN |
| 03/23/2006 | WO2004006753A3 Sga-72m, a cancer associated antigen, and uses thereof |